Selective CDK inhibitors: Promising candidates for future clinical traumatic brain injury trials

Neural Regeneration Research

Volumn 9, Issue 17, 2014, Pages 1578-1580

  Kabadi, Shruti V ^a   Faden, Alan I ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Cell cycle inhibition; CR 8; Lateral fluid percussion; Microglial activation; Neurodegeneration; Roscovitine

Indexed keywords

BROXURIDINE; CR 8; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; FLAVOPIRIDOL; NEURON SPECIFIC NUCLEAR PROTEIN; RETINOBLASTOMA PROTEIN; ROSCOVITINE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL CYCLE; CELL LOSS; CELL PROLIFERATION; COGNITION; COGNITIVE DEFECT; DNA SYNTHESIS; DRUG EFFICACY; DRUG METABOLISM; HIPPOCAMPUS; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; TRAUMATIC BRAIN INJURY;

EID: 84929933220     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.141779     Document Type: Article

References (32)

1. Arendt T (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the ‘Dr. Jekyll and Mr. Hyde concept’ of Alzheimer’s disease ordisease or the yin and yang of neuroplasticity. Prog Neurobiol 71:83-248.
2. Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L (2008) CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene 27:5797-5807.
3. Bettayeb K, Baunbaek D, Delehouze C, Loaec N, Hole AJ, Baumli S, Endicott JA, Douc-Rasy S, Benard J, Oumata N, Galons H, Meijer L (2010) CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells. Genes Cancer 1:369-380.
4. Bramlett H, Dietrich W (2007) Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res 161:125-141.
5. Byrnes K, Faden A (2007) Role of cell cycle proteins in CNS injury. Neurochem Res 32:1799-1807.
6. Byrnes KR, Loane DJ, Stoica BA, Zhang J, Faden AI (2012) Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation 9:43.
7. Cernak I, Stoica B, Byrnes K, Di Giovanni S, Faden A (2005) Role of the cell cycle in the pathophysiology of central nervous system trauma. Cell cycle 4:1286-1293.
8. Chirumamilla S, Sun D, Bullock MR, Colello RJ (2002) Traumatic brain injury induced cell proliferation in the adult mammalian central nervous system. J Neurotrauma 19:693-703.
9. Faul M, Xu L, Wald M, Coronado V (2010) Traumatic brain injury in the United States: Emergency department visits, hospitalizations and deaths 2002-2006 In. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
10. Giovanni SD, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden A (2005) Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 102:8333-8338.
11. Greene L, Biswas S, Liu D (2004) Cell cycle molecules and vertebrate neuron death: E2F at the hub. Cell Death Differ 11:49-60.
12. Hilton GD, Stoica BA, Byrnes KR, Faden AI (2008) Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab 28:1845-1859.
13. Kabadi SV, Hilton GD, Stoica BA, Zapple DN, Faden AI (2010) Fluid- percussion-induced traumatic brain injury model in rats. Nat Protoc 5:1552-1563.
14. Kabadi SV, Stoica BA, Byrnes KR, Hanscom M, Loane DJ, Faden AI (2012a) Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab 32:137-149.
15. Kabadi SV, Stoica BA, Loane DJ, Byrnes KR, Hanscom M, Cabatbat RM, Tan MT, Faden AI (2012b) Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury. J Neurotrauma 29:813-827.
16. Kabadi SV, Stoica BA, Loane DJ, Luo T, Faden AI (2014) CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab 34:502-513.
17. Kanaan NM, Kordower JH, Collier TJ (2010) Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol Aging 31:937-952.
18. Komina O, Nosske E, Maurer M, Wesierska-Gadek J (2011) Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells. J Exp Ther Oncol 9:27-35.
19. Loane DJ, Faden AI (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 31:596-604.
20. Long JM, Kalehua AN, Muth NJ, Calhoun ME, Jucker M, Hengemihle JM, Ingram DK, Mouton PR (1998) Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging 19:497-503.
21. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536.
22. Nandoe R (2002) Head trauma and Alzheimer’s disease. J Alzheimer’s Dis 4:303-308.
23. Nguyen M, Boudreau M, Kriz J, Couillard-Despres S, Kaplan D, Julien J (2003) Cell cycle regulators in the neuron death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci 23:2131-2140.
24. Nutley BP, Raynaud FI, Wilson SC, Fischer PM, Hayes A, Goddard PM, McClue SJ, Jarman M, Lane DP, Workman P (2005) Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse. Mol Cancer Ther 4:125-139.
25. Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS, Hakim AM, Ikeda JE, Park DS (2000) Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci U S A 97:10254-10259.
26. Panter SS, Faden AI (1992) Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett 136:165-168.
27. Slattery DA, Cryan JF (2012) Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 7:1009-1014.
28. Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K (2001) Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res 63:90-97.
29. Stoica BA, Byrnes KR, Faden AI (2009) Cell cycle activation and CNS injury. Neurotox Res 16:221-237.
30. Taupin P (2007) BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev 53:198-214.
31. Urrea C, Castellanos DA, Sagen J, Tsoulfas P, Bramlett HM, Dietrich WD (2007) Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat. Restor Neurol Neurosci 25:65-76.
32. Wesierska-Gadek J, Gritsch D, Zulehner N, Komina O, Maurer M (2011) Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen- induced phosphorylation of ER-alpha in human ER-positive breast cancer cells. J Cell Biochem 112:761-772.